Source 1primary paper2025MED
Toolkit/multiparametric flow cytometry
multiparametric flow cytometry
Taxonomy: Technique Branch / Method. Workflows sit above the mechanism and technique branches rather than replacing them.
Summary
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Usefulness & Problems
Why this is useful
Multiparametric flow cytometry is described as an advanced tool for identifying novel tumor-specific targets. The abstract also associates it with improving therapy designs.; identifying novel tumor-specific targets; improving therapy designs
Source:
Multiparametric flow cytometry is described as an advanced tool for identifying novel tumor-specific targets. The abstract also associates it with improving therapy designs.
Source:
identifying novel tumor-specific targets
Source:
improving therapy designs
Problem solved
insufficient target identification for improved CAR-T design
Source:
insufficient target identification for improved CAR-T design
Problem links
insufficient target identification for improved CAR-T design
LiteratureMultiparametric flow cytometry is described as an advanced tool for identifying novel tumor-specific targets. The abstract also associates it with improving therapy designs.
Source:
Multiparametric flow cytometry is described as an advanced tool for identifying novel tumor-specific targets. The abstract also associates it with improving therapy designs.
Taxonomy & Function
Primary hierarchy
Technique Branch
Method: A concrete measurement method used to characterize an engineered system.
Mechanisms
No mechanism tags yet.
Target processes
No target processes tagged yet.
Implementation Constraints
cofactor dependency: cofactor requirement unknownencoding mode: genetically encodedimplementation constraint: context specific validationoperating role: sensor
Operational role: sensor. Implementation mode: genetically encoded. Cofactor status: cofactor requirement unknown.
Independent follow-up evidence is still limited. Validation breadth across biological contexts is still narrow. Independent reuse still looks limited, so the evidence base may be fragile. No canonical validation observations are stored yet, so context-specific performance remains under-specified.
Validation
Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication
Supporting Sources
Ranked Claims
Multi-targeting strategies including logic-gated CARs, adapter CARs, and combination therapies can increase CAR-T cell potency and aim to minimize immune evasion by simultaneously targeting multiple antigens.
multi-targeting strategies like logic-gated CARs, adapter CARs, or combination therapies can increase the potency of CAR-T cells. These approaches aim to minimize immune evasion by targeting multiple antigens simultaneously
Single-antigen CAR-T therapies can fail through immune evasion caused by antigen escape.
most CAR-T therapies target a single antigen, such as CD19, which can result in immune evasion through antigen escape
CRISPR screening and single-cell RNA sequencing can support personalization that enhances durability and effectiveness of treatments for heavily pretreated patients.
Personalization using advanced technologies like CRISPR screening and single-cell RNA sequencing can enhance durability and effectiveness of treatments for heavily pretreated patients
NGS, dSTORM, and multiparametric flow cytometry help identify novel tumor-specific targets and improve CAR-T therapy designs.
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Approval Evidence
1 source1 linked approval claimfirst-pass slug multiparametric-flow-cytometry
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Source:
use casesupports
NGS, dSTORM, and multiparametric flow cytometry help identify novel tumor-specific targets and improve CAR-T therapy designs.
advanced tools such as next-generation sequencing (NGS), direct stochastic optical reconstruction microscopy (dSTORM), or multiparametric flow cytometry are helping to identify novel tumor-specific targets and improve therapy designs
Source:
Comparisons
Source-backed strengths
presented as an advanced tool supporting target discovery
Source:
presented as an advanced tool supporting target discovery
Compared with fluorescence line narrowing
multiparametric flow cytometry and fluorescence line narrowing address a similar problem space.
Shared frame: same top-level item type
Compared with Langendorff perfused heart electrical recordings
multiparametric flow cytometry and Langendorff perfused heart electrical recordings address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Compared with native green gel system
multiparametric flow cytometry and native green gel system address a similar problem space.
Shared frame: same top-level item type
Strengths here: looks easier to implement in practice.
Ranked Citations
- 1.